Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen

References

• Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005;57:1595–1639
   PubMed Web of Science ®Google Scholar
• Boddu SH, Gupta H, Patel S. Drug delivery to the back of the eye following topical administration: an update on research and patenting activity. Recent Pat Drug Deliv Formul 2014;8:27–36
   PubMedGoogle Scholar
• Gaudana R, Jwala J, Baddu SH, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res 2009;26:1197–1216
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobão P, et al. Applications of polymeric and lipid nanoparticles in ophthalmic pharmaceutical formulations: present and future considerations. J Pharm Pharm Sci 2014;17:278–293
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobão P, Sousa Lobo JM. In situ gelling systems: a strategy to improve the bioavailability of ophthalmic pharmaceutical formulations. Drug Discov Today 2014;19:400–412
   PubMed Web of Science ®Google Scholar
• Sasaki H, Yamamura K, Nishida K, et al. Delivery of drugs to the eye by topical application. Prog Ret Eye Res 1996;15:583–620
   Web of Science ®Google Scholar
• Nirmal HB, Bakliwal SR, Pawar SP. In-situ gel: new trends in controlled and sustained drug delivery system. Int J PharmTech Res 2010;2:1398–1408
   Google Scholar
• Agarwal KI, Mehta N, Namdev A, et al. In-situ gel formation for ocular drug delivery system an overview. Asia J Bio Pharm Sci 2011;1:1–7
   Google Scholar
• Champalal KD, Sushilkumar P. Current status of ophthalmic in-situ forming hydrogel. Int J Pharm Bio Sci 2012;3:372–388
   Google Scholar
• Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995;16:61–73
   Web of Science ®Google Scholar
• Meisner D, Mezei M. Liposome ocular delivery systems. Adv Drug Deliv Rev 1995;16:75–93
   Web of Science ®Google Scholar
• Li X, Zhang Z, Wang M, et al. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 2009;379:131–138
   PubMed Web of Science ®Google Scholar
• Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 2010;29:596–609
   PubMed Web of Science ®Google Scholar
• Souto EB, Doktorovova S, Gonzalez-Mira E, et al. Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs. Curr Eye Res 2010;35:537–552
   PubMed Web of Science ®Google Scholar
• Gan L, Wang J, Jiang M, et al. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today 2013;18:290–297
   PubMed Web of Science ®Google Scholar
• Araújo J, Vega E, Lopes C, et al. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces 2009;72:48–56
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Gokce E, Ozyazici M, Souto EB. Lipid matrix nanoparticles. Pharmacokinetics and biopharmaceutics. Curr Nanosci 2009;5:358–371
   Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, et al. Nanoparticles laden in situ gel of levofloxacin for enhanced ocular retention. Drug Deliv 2013;20:306–309
   PubMed Web of Science ®Google Scholar
• Gupta H, Aqil M, Khar RK, et al. Nanoparticles laden in situ gel for sustained ocular drug delivery. J Pharm Bioalled Sci 2013;5:162–165
   PubMedGoogle Scholar
• Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131–155
   PubMed Web of Science ®Google Scholar
• Doktorovova S, Souto EB. Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review. Expert Opin Drug Deliv 2009;6:165–175
   PubMed Web of Science ®Google Scholar
• Araújo J, Nikolic S, Egea MA, et al. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf B Biointerfaces 2011;88:150–157
   PubMed Web of Science ®Google Scholar
• Hao J, Wang X, Bi Y, et al. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery. Colloids Surf B Biointerfaces 2014;114:111–120
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobão P, Sousa Lobo JM. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert Opin Drug Deliv 2013;10:1223–1237
   PubMed Web of Science ®Google Scholar
• Jeong B, Gutowska A. Lessons from Nature: stimuli-responsive polymers and their biomedical applications. Trends Biotechnol 2002;20:305–310
   PubMed Web of Science ®Google Scholar
• Kumar A, Srivastata A, Galaev IY, Mattiasson B. Smart polymers: physical forms and bioengineering applications. Prog Polym Sci 2007;32:1205–1237
   Web of Science ®Google Scholar
• Rupenthal ID, Green CR, Alany RG. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part I: physicochemical characterization an in vitro release. Int J Pharm 2011;411:69–77
   PubMed Web of Science ®Google Scholar
• El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm 2002;241:47–55
   PubMed Web of Science ®Google Scholar
• Bawa P, Pillay V, Choonara YE, Toit LC. Stimuli-responsive polymers and their applications in drug delivery. Biomed Mater 2009;4:1–15
   Web of Science ®Google Scholar
• Baeyens V, Percicot C, Zignani M, et al. Ocular drug delivery in veterinary medicine. Adv Drug Deliv Rev 1997;28:335–361
   PubMed Web of Science ®Google Scholar
• Escobar-Chávez JJ, López-Cervantes M, Naik A, et al. Applications of thermoreversible Pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006;9:339–358
   PubMed Web of Science ®Google Scholar
• Almeida H, Amaral MH, Lobão P, Sousa Lobo JM. Influence of drug incorporation, temperature and storage time on the ph, textural and rheological properties of different poloxamer hydrogels. Curr Drug Deliv 2013;10:1–12
   Web of Science ®Google Scholar
• Achouri D, Alhanout K, Piccerelle P, Andrieu V. Recent advances in ocular drug delivery. Drug Dev Ind Pharm 2013;39:1599–1617
   PubMed Web of Science ®Google Scholar
• Kim S, Kim JH, Jeon O, et al. Engineered polymers for advanced drug delivery. Eur J Pharm Biopharm 2009;71:420–430
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Ferrara P, et al. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci 2002;16:53–61
   PubMed Web of Science ®Google Scholar
• Li X, Nie SF, Kong J, et al. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008;363:177–182
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Mishra B, Singh S. Lipid-an emerging platform for oral delivery of drugs with poor bioavailability. Eur J Pharm Biopharm 2009;73:1–15
   PubMed Web of Science ®Google Scholar
• Mendes AI, Silva AC, Catita JAM, et al. Miconazole-loaded nanostructured lipid carriers (NLC) for local delivery to the oral mucosa: improving antifungal activity. Colloids Surf B Biointerfaces 2013;111:755–763
   PubMed Web of Science ®Google Scholar
• Silva AC, González-Mira E, García ML, et al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf B Biointerfaces 2011;86:158–165
   PubMed Web of Science ®Google Scholar
• Silva AC, Kumar A, Wild W, et al. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Int J Pharm 2012;436:798–805
   PubMed Web of Science ®Google Scholar
• Chang JY, Oh YK, Kong HS, et al. Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release 2002;82:39–50
   PubMed Web of Science ®Google Scholar
• Qi H, Chen W, Huang C, et al. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm 2007;337:178–187
   PubMed Web of Science ®Google Scholar
• Prista LN, Alves AC, Morgado R, Sousa Lobo JM. Tecnologia farmacêutica. 6st ed. Lisboa: Fundação Calouste Gulbenkian; 2002
   Google Scholar
• Sinko PJ. Martin’s physical pharmacy and pharmaceutical sciences. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2011
   Google Scholar
• Troy DB, Beringer P. Remington: the science and practice of pharmacy. 21st ed. Philadelphia: Lippincott Williams & Wilkins; 2006
   Google Scholar
• Zignani M, Tabatabay C, Gurny R. Topical semi-solid drug delivery: kinetics and tolerance of ophthalmic hydrogels. Adv Drug Deliv Rev 1995;16:51–60
   Web of Science ®Google Scholar
• Gilbert JC, Richardson JL, Davies MC, Palin KJ. The effect of solutes and polymers on the gelation properties of pluronic F-127 solutions for controlled drug delivery. J Control Deliv 1987;5:113–118
   Google Scholar
• Gong C, Shi S, Dong P, et al. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm 2009;365:89–99
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC. Colloids Surf B Biointerfaces 2010;81:412–421
   PubMed Web of Science ®Google Scholar
• Martins S, Tho I, Souto E, et al. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. Eur J Pharm Sci 2012;45:613–623
   PubMed Web of Science ®Google Scholar
• Fangueiro JF, Andreani T, Egea MA, et al. Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process. Colloids Surf B Biointerfaces 2012;100:84–89
   PubMed Web of Science ®Google Scholar
• Fangueiro JF, Andreani T, Fernandes L, et al. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation. Colloids Surf B Biointerfaces 2014;123:452–460
   PubMed Web of Science ®Google Scholar
• Fangueiro JF, Andreani T, Egea MA, et al. Design of cationic lipid nanoparticles for ocular delivery: development, characterization and cytotoxicity. Int J Pharm 2014;461:64–73
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, et al. Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B Biointerfaces 2009;72:155–160
   PubMed Web of Science ®Google Scholar
• Souto EB, Müller RH. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. Handb Exp Pharmacol 2010;197:115–141
   PubMedGoogle Scholar
• Araújo J, Gonzalez-Mira E, Egea MA, et al. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm 2010;393:167–175
   PubMed Web of Science ®Google Scholar
• Tian BC, Zhang WJ, Xu HM, et al. Further investigation of nanostructured lipid carriers as an ocular delivery system: in vivo transcorneal mechanism and in vitro release study. Colloids Surf B Biointerfaces 2013;102:251–256
   PubMed Web of Science ®Google Scholar
• Almeida IF, Bahia MF. Evaluation of the physical stability of two oleogels. Int J Pharm 2006;327:73–77
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha EM, et al. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 2010;75:186–193
   PubMed Web of Science ®Google Scholar
• Portuguese Pharmacopeia 9.0. Lisboa: Infarmed – Ministério da Saúde; 2009
   Google Scholar
• Wang F, Chen L, Zhang D, et al. Methazolamide-loaded solid lipid nanoparticles modified with low-molecular weight chitosan for the treatment of glaucoma: vitro and vivo study. J Drug Target 2014;22:849–858
   PubMed Web of Science ®Google Scholar
• ICH. Validation of analytical procedures: text and methodology Q2(R1), ICH Harmonised Tripartite Guideline; 2005
   Google Scholar
• Araújo J, Gonzalez E, Egea MA, et al. Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine 2009;5:394–401
   PubMed Web of Science ®Google Scholar
• Silva AC, Amaral MH, González-Mira E, et al. Solid lipid nanoparticles (SLN)-based hydrogels as potential carriers for oral transmucosal delivery of Risperidone: preparation and characterization studies. Colloids Surf B Biointerfaces 2012;93:241–248
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Z, Chen H. Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac. Int J Pharm 2013;448:96–100
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today 2008;13:144–151
   PubMed Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Singh PN, et al. Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 2009;136:2–13
   PubMed Web of Science ®Google Scholar
• Neves AR, Lúcio M, Martins S, et al. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int J Namomedicine 2013;8:177–187
   PubMed Web of Science ®Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, et al. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008;68:513–525
   PubMed Web of Science ®Google Scholar
• Shen J, Wang Y, Ping Q, et al. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Control Release 2009;137:217–223
   PubMed Web of Science ®Google Scholar
• Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161–177
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. Effects of emulsifiers on the controlled release of Paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release 2001;71:53–69
   PubMed Web of Science ®Google Scholar
• Yuan Y, Gao Y, Zhao J, Mao L. Characterization and stability evaluation of β-carotene nanoemulsions prepared by high pressure homogenization under various emulsifying conditions. Food Res Int 2008;41:61–68
   Web of Science ®Google Scholar
• Gonzalez-Mira E, Nikolic S, Calpena AC, et al. Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC based hydrogels. J Pharm Sci 2012;101:707–725
   PubMed Web of Science ®Google Scholar
• Wulff-Pérez M, Gálvez-Ruíz MJ, Vicente J, Martín-Rodríguez A. Delaying lipid digestion through steric surfactant Pluronic F68: a novel in vitro approach. Food Res Int 2010;43:1629–1633
   Web of Science ®Google Scholar
• Lamprecht A, Saumet JL, Roux J, Benoit JP. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment. Int J Pharm 2004;278:407–414
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Souto EB, Műller RH. Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR. Pharmazie 2005;60:508–513
   PubMed Web of Science ®Google Scholar
• Müller RH, Runge SA, Ravelli V, et al. Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation. Eur J Pharm Biopharm 2008;68:535–544
   PubMed Web of Science ®Google Scholar
• Lenaerts V, Triqueneaux C, Quarton M, et al. Temperature-dependent rheological behaviour of Pluronic F-127 aqueous solutions. Int J Pharm 1987;39:121–127
   Web of Science ®Google Scholar
• Shelke NB, Rokhade AP, Aminabhavi TM. Preparation and evaluation of novel blend microspheres of poly(lactic-co-glycolic)acid and Pluronic F68/127 for controlled release of repaglinide. J Appl Polym Sci 2010;160:366–372
   Web of Science ®Google Scholar
• Shelke NB, Aminabhavi TM. Synthesis and characterization of novel poly(sebacic anhydride-co-Pluronic F68/F127) biopolymeric microspheres for the controlled release of nifedipine. Int J Pharm 2007;345:51–58
   PubMed Web of Science ®Google Scholar